2018 Skin Cancer Summit and Masterclasses
Planning has already begun for the 2018 Skin Cancer Summit and Masterclasses!
We were thrilled to bring you four days of learning and entertainment with world’s top skin cancer experts during our 2017 conference – and come July 2018, we will be back in Brisbane with Australia’s leading skin cancer event.
Join us on 25-28 July 2018 in Brisbane for the 2018 Skin Cancer Summit and Masterclasses, with over 300 other
Two days of masterclasses prior to the summit with international experts, giving you the unique opportunity to hear from the world’s best and walk away with knowledge to excel at what you do.
The two-day summit features renowned skin cancer experts who deliver the latest clinical content on skin cancer management, bringing you up to date and stretching your thinking in this innovative field.
The social program offers a variety of networking opportunities with your peers and the presenters, including an exceptional Gala dinner with professionals who share your passion for skin cancer medicine.
Professor at the Department of Dermatology, Medical University of Vienna, Austria
Research Director of the Non-Melanoma Skin Cancer Unit. Division of Dermatology and Venerology, Medical University of Graz, Austria
Dr Iris Zalaudek is a Board-certiﬁed dermatologist and Director of the Non-Melanoma and Orphan Skin Cancer Unit at the Division of Dermatology of the Medical University of Graz, Austria. Since 2016, she has been President of the International Dermoscopy Society.
Her main research ﬁelds are related to dermato-oncology and include non-invasive skin imaging techniques, as well as topical and systemic treatment of skin cancer. Moreover, she is engaged in the development of modern teaching methods such as online distant courses and tele-dermatologic services. She is Director of the Master of Science program entitled "Dermoscopy and Preventive Dermato-Oncology" of the Medical University of Graz, Austria.
Iris has published more than 450 articles, of which 358 (267 full papers) have been cited in PubMed. Her combined publications have received an impact factor of 1003 and a h-index value of 36 (by April 2017). In 2003 her work was awarded by the Hans-Weitgasser Price from the Styrian Association of Dermatologists and in 2008 she was awarded the Best Researcher of the Medical University of Graz, Austria.
MBBS PhD FSCCA
Associate Professor and Director MMed (Skin Cancer) Program School of Medicine, The University of Queensland
Associate Professor Cliff Rosendahl currently works in Brisbane, Australia as a primary care practitioner with a special interest in skin cancer. He also has an interest in research as the clinical developer and Director of the Skin Cancer Audit Research Database (SCARD). His other main area of research has been in evaluating dermatoscopic clues for the diagnosis of both pigmented and non-pigmented skin malignancy in collaboration with colleagues at The University of Queensland, Australia and the Medical University of Vienna, Austria.
Cliff has a strong commitment to teaching with a view to achieving an improvement in both the detection and management of skin cancer in Australasia and internationally.
MBBS (Hons), MMed, FACRRM, FSSCA
Skin Cancer Physician at Milton Skin Cancer Clinic, NSW South Coast, Australia
Mayne Professor and Head, Discipline of Surgery, The University of Queensland
Director, Upper Gastro-intestinal and Soft Tissue Unit, Princess Alexandra Hospital
Chairman, Queensland Melanoma Project
Director, Melanoma Patients Australia
Executive, Section of Academic Surgery, Royal Australasian College of Surgeons
Dr Mark Smithers is a surgeon associated with the multi-disciplinary Melanoma Clinic at the Princess Alexandra Hospital, managing patients with all stages of the disease. He is actively researching the epidemiological aspects (in collaboration with QIMR Berghofer) and surgical management of melanoma (NH&MRC, UQ Cancer Research fund, Cancer Council of Queensland).
Mark is also the principle investigator on multi-centre NIH sponsored and industry lead phase I, II and III trials for patients with advanced stages of melanoma.
Deputy Director, Dermatology Research Centre
The University of Queensland, Faculty of Medicine + Biomedical Sciences Translational Research Institute, Australia
Having earned a Ph.D. from the University of Texas in the field of Nanomedicine, Dr Tarl Prow completed his T32 funded post-doc at the Wilmer Eye Institute at The Johns Hopkins Hospital and was at the faculty there until relocating to The University of Queensland. Tarl has established programs for developing novel computational, nanotechnologies and microtechnologies for detecting and treating skin cancer. His research program bridges strengths in microdevices, nanomedicine and non-invasive imaging for applications in the fields of skin cancer prevention, preventing photoageing, and early skin cancer diagnosis. Within this framework his laboratory has active projects in:
(1) enhanced cutaneous delivery technologies for antioxidants and chemotherapeutic drugs to fight photoageing and skin cancer;
(2) objective photodamage and skin cancer precursor detection/assessment tools using non-invasive microscopy coupled with artificial intelligence; and
(3) ultra small biopsy devices for minimally invasive molecular diagnostics. The development of these technologies will enable a step-change in dermatology patient care and underpins his overarching goal of reducing the skin cancer burden.
2017 SPONSORS AND EXHIBITORS
Sonic Skin Dx
We oﬀer the most comprehensive dermatopathology service in Australia—one that’s consistently outstanding no matter where you are located. Our pathologists are world leaders: their experience, expertise, and commitment to professional development gives you the assurance that the diagnoses we deliver are accurate and reliable. Because we’re a comprehensive laboratory, you can also be assured that your patients have access to all pathology disciplines.
At Sullivan Nicolaides Pathology we understand that you need quick, accurate, and reliable diagnoses to best manage your patients’ conditions.
The Critical Group formed in 1983 and traded under the name 'Critical Assist'. Its business is focused on distribution of product in all Australian states. Since 2008 The Critical Group has changed its name and focus and expanded its operations under the new owners' guidance and strategic direction. The Critical Group is based in Sydney. The Critical Group have a national sales force with representatives servicing the whole Australian market with an established customer base. Our team are experienced in technical sales and the marketing of innovative medical technologies.
Australian Skin Cancer Clinics began in 1999 and has expanded to over 20 clinics in New South Wales,
Queensland, Victoria and Western Australia and is continuing to grow rapidly. Australian Skin Cancer Clinics was acquired by Independent Practitioner Network in 2011, strengthening the service oﬀering with the support of a leading healthcare service provider. Our aim is to provide caring, accessible and eﬃcient service for early detection, diagnosis, treatment and management of skin cancer in the primary care setting. We are also active in promoting skin cancer awareness and prevention.
Warner & Webster Established in the late 1800's, Warner & Webster Pty Ltd continues to be one of Australia's most progressive surgical supply houses. We specialise in: Surgery set‐ups / Medical consumables / Latest Medical Equipment Equipment – dermatoscopes, couches, trolleys, procedural lights, ECG's, autoclaves, spirometers, dopplers, oximeters, stethoscopes, BP machines, diagnostic sets and much, much more. We provide all the latest technology, advice, great pricing and total customer satisfaction. www.warnerwebster.com.au
Low prices and expert advice on medical equipment. DocStock oﬀers the best of both worlds: Online savings on quality medical equipment, with friendly, expert advice and support. GPs, Medical Professionals, Nursing Homes, Hospitals, Universies, and home users continue to trust DocStock, Australia's original online medical supplier, for their medical equipment. DocStock allows you to calculate delivery costs before you order, and pay using a safe method that suits you. Our large product images and clear information make it simple to buy the right medical product online.
With many years of international dermatological expertise, Swiss company Stratpharma has developed breakthrough treatments for faster wound healing, abnormal scar prevention and treatment that are now available in over 50 countries. These silicone-based products are clinically proven to be effective and easy to use alone or in combination with more invasive therapies. Stratpharma’s range includes:
- Stratamed – the first film-forming silicone-based wound dressing approved for use on open wounds and compromised skin
- Strataderm – for the treatment of old and new scars
- Stratamark – for the prevention and treatment of stretch marks
- StrataXRT – for the prevention and treatment of radiation dermatitis
Effective, affordable and easy to use skin care. asap's mission is to provide stockists and consumers with the highest quality cosmeceutical products, specifically formulated to help achieve beautiful, healthy and younger looking skin.
Microplus+ - the latest microdermabrasion and ultrasonic technology is an Australian made device - portable, silent and easy to use. Your answer to beautiful skin with long lasting results.
asap is Australia’s No1 Cosmeceutical brand and offers superior training and support to skin care professionals worldwide.
100% Australian made and owned, our products are:
·Paraben free ·SLS/SLES free ·Mineral oil free ·Synthetic dye free ·Artificial fragrance free ·Animal derivative free ·Not tested on animals
A global dermatology company committed to delivering innovative medical solutions to meet the needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 34 wholly‐owned aﬃliates and a worldwide network of distributors, over 5.000 employees and an extensive product portfolio available in 80 countries. With approximately 19% of revenues invested each year to discover and develop new dermatology solutions and products and access innovative technologies, the dermatology company is one of the world's leading investors in dermatology R&D. Five state‐of‐the‐art R&D centres and ﬁve manufacturing sites are dedicated to providing a wide range of innovative medical solutions which meet the highest standards of safety and eﬃcacy.
Ego Pharmaceuticals is an Australian family-owned and operated company who for more than 50 years have specialised in the manufacture of quality skin care products such as market leaders “Sunsense”, “QV”, “Pinetarsol”, “DermAid” and “Moov”. Now the great news is, you can order Ego products online. Visit our display stand, see how easy it is to register and talk to us about “Sunsense”, our wide range of high SPF sunscreens and “QV” moisturisers and cleansers.
Discover Firstcheck's free teledermatology software + dermoscope - connecting you with patients + referring clinicians, remotely
- For triage, prioritisation, diagnosis or management plan remote support
- For use with patients introduced to you by Firstcheck, your existing patients + referring clinicians
- No set-up or ongoing costs + be paid to review cases
- Connecting more patients with skin cancer doctors
Visit us at Booth 16 to find out more, see it in action + discover how you can be up + running in just minutes!